No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs2778908 |
chr9:101345778-101345779 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs182219714 |
chr9:101345789-101345790 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs578065420 |
chr9:101345800-101345801 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs553214104 |
chr9:101345825-101345826 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs540324690 |
chr9:101345859-101345860 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs560314179 |
chr9:101345878-101345879 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs145592592 |
chr9:101345903-101345904 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs369366955 |
chr9:101346007-101346008 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs148460954 |
chr9:101346018-101346019 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs77412307 |
chr9:101346107-101346108 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs532011826 |
chr9:101346128-101346129 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs375998826 |
chr9:101346153-101346154 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs1167763 |
chr9:101346168-101346169 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
14 |
rs564101408 |
chr9:101346267-101346268 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs185241905 |
chr9:101346301-101346302 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs546672655 |
chr9:101346316-101346317 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs75383984 |
chr9:101346324-101346325 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs35228818 |
chr9:101346354-101346355 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs535616829 |
chr9:101346396-101346397 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs549176772 |
chr9:101346415-101346416 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs369380074 |
chr9:101346433-101346434 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs75442259 |
chr9:101346440-101346441 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs113382877 |
chr9:101346459-101346460 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs7870213 |
chr9:101346466-101346467 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs560115746 |
chr9:101346488-101346489 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs577920001 |
chr9:101346532-101346533 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs10123407 |
chr9:101346548-101346549 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs190000444 |
chr9:101346553-101346554 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs182666432 |
chr9:101346584-101346585 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs542843798 |
chr9:101346622-101346623 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs2779528 |
chr9:101346661-101346662 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
32 |
rs7872671 |
chr9:101346691-101346692 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs564127344 |
chr9:101346713-101346714 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs185516557 |
chr9:101346728-101346729 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs1186021 |
chr9:101346757-101346758 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
36 |
rs201805637 |
chr9:101346776-101346777 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs532916230 |
chr9:101346886-101346887 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs200111086 |
chr9:101347057-101347058 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs142635147 |
chr9:101347072-101347073 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs528980914 |
chr9:101347089-101347090 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs549238095 |
chr9:101347092-101347093 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs554336953 |
chr9:101347093-101347094 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs569027781 |
chr9:101347130-101347131 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs531507593 |
chr9:101347145-101347146 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs191220333 |
chr9:101347146-101347147 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs533282728 |
chr9:101347188-101347189 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs540386603 |
chr9:101347202-101347203 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs73494498 |
chr9:101347208-101347209 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
49 |
rs12337255 |
chr9:101347219-101347220 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
50 |
rs544493780 |
chr9:101347254-101347255 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|